TIANJIN MINXIANG BIOMEDICAL INC.(stock code: 834738), established in 2005, is a state-level high-tech enterprise mainly engaged in the research and development, production and sales of pharmaceutical products. It has three wholly-owned subsidiaries.

        The company has a large number of professional R & D personnel, whose professional fields involve chemical synthesis, chemical process development, biological fermentation, drug substance process development, testing and quality analysis, etc. The company hires some industry experts to serve as company technical consultants and collect information on new products for the company Provides strong guidance on R & D problem solving and scientific research cooperation.

        The company always adheres to the "industry-research-research joint innovation" technology innovation system, and cooperates with outstanding experts and technical personnel of well-known domestic universities to develop applied technologies for pharmaceutical raw materials and intermediate products.

        The company adheres to the strategic idea of ?“professional scientific research and development as the core and enhances the comprehensive competitiveness of the enterprise”, based on product innovation, and solidly carries out technological innovation activities. The company encourages and supports the research and development of new drugs and technological innovation, continuously increases investment in scientific research, implements product structure adjustment, and comprehensively improves the company's technology research and development capabilities. And the company actively cooperates with various universities and research institutes to research, and actively introduces various talents to enrich the research and development strength.